Use of liver growth factor (lgf) as a neural tissue regenerator
AssigneeFun Par La Inves Bio Del Hos Uni Puerta De Hierro
InventorJuan Jose Diaz Gil
Life of this patent
Estimating the term…
Abstract
The invention comprises the use of LGF in the production of medicinal products that can be used in the pleiotropic tissue regeneration of one or more damaged tissues, in which at least one of the damaged tissues forms part of the central nervous system and the medicinal product is intended to be administered systemically. The invention is based on the fact that intraperitoneal administration of LGF can promote a positive effect on a Parkinson's disease model. As such, in a preferred embodiment of the invention, the medicinal product is intended for the treatment of Parkinson's disease, particularly when the medicinal product is intended for humans.
Claims20
A method of manufacturing a medicinal product suitable for pleiotropic tissue regeneration of at least one damaged tissue, the method comprising adding liver growth factor (LGF), or lyophilized LGF, to a pharmaceutically acceptable aqueous vehicle, wherein the at least damaged tissue forms part of the central nervous system and the medicinal product is designed to be administered systemically.
A method of treating a disorder or disease whose severity or risk of deterioration decreases with the regeneration of at least one tissue,
- said method comprising administering an effective amount of liver growth factor to a human being or an animal in need thereof by a systemic route
- wherein said disorder or disease is selected from those associated with the central nervous system.
A method of regenerating pleiotropic tissue of at least one damaged central nervous system tissue, the method comprising administering an effective amount of liver growth factor (LGF) to a subject in need thereof.
Dependencies are inferred from the claim text.